FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for ALBUTEROL SULFATE from Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. under an ANDA for a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchospasm
• Chronic Obstructive Pulmonary Disease
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Albuterol sulfate (Albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE (ALBUTEROL SULFATE)